Organic volatile impurities: A regulatory overview

Pharma Times

Volumn 44, Issue 5, 2012, Pages 25-30

  Kushwaha, Poonam ^a  

^a INTEGRAL UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ORGANIC SOLVENT; VOLATILE ORGANIC COMPOUND;

ARTICLE; CHEMICAL ANALYSIS; CONCENTRATION (PARAMETERS); DRUG CONTAMINATION; DRUG CONTROL; DRUG IMPURITY; DRUG INDUSTRY; DRUG MANUFACTURE; DRUG QUALITY; DRUG SAFETY; ENVIRONMENTAL HEALTH; ENVIRONMENTAL PROTECTION; HEALTH HAZARD; MEDICAL LITERATURE; PRACTICE GUIDELINE; QUALITY CONTROL; TOXICITY TESTING;

EID: 84861544460     PISSN: 00316849     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Michulec M., Wardenki, W.; Development of headspace solidphase micro-extraction-gas chromatography method for the determination of solvent residues in edible oils and pharmaceuticals, J. Chromatogr, 2005; 1071: 119-124.
2. Dwivedi A. M., Residual solvent analysis in pharmaceuticals. Pharmaceutical Technology 2002; 42-46.
3. Camarasu C., Unknown residual solvents-identification in drug products by headspace solid phase microextraction gas chromatography and mass spectroscopy, Chromatographia 2002; 56: S131-S135.
4. Rocheleau MJ., Measuring residual solvents in pharmaceutical samples using fast gas chromatography techniques, J. Chromatogr. B 2004; 805: 77-86.
5. B'Hymer C., Residual solvent testing: A review of gas chromatographic and alternative techniques, Pharm. Res. 2003; 20, 337-343.
6. Otero, R., Carrera, G., Static headspace gas chromatographic method for quantitative determination of residual solvents in pharmaceutical drug substances according to European pharmacopoeia requirements, J. Chromatogr. A 2004; 1057: 193-201.
7. ICH Q3(C), Impurities: residual solvents, 1997.
8. Countrymen, S. Understanding the revision to USP monograph 467; residual solvents, phenomenex Inc. Torrance, CA, USA, 2007.
9. General chapters 466; «Ordinary impurities» and 1086, «Impurities in official articles,» in USP 28--NF 23. US Pharmacopoeia. 12601 Twin brook Parkway, Rockville, Maryland 20852, USA, 2004.
10. European pharmacopoeia, Identification and control of residual solvents (2.4.24), directorate for the quality of medicines of the Council of Europe, Strasbourg, France, 2005, 5th edition, pp. 96.
11. European Pharmacopoeia, General chapter 5.10, Control of impurities in substances for pharmaceutical use and general monograph: 2034, substances for pharmaceutical use, 2005, 5th edition. pp 559-561, 586-587.
12. Morris, J.M., Regulation of residual solvents in medicinal products in the European Union, Irish Medicines Board, 2007.
13. Japanese Pharmacopoeia, Residual solvent testing, Society of Japanese Pharmacopoeia, 14th edition.
14. Wood, D. C., Miller, J. M.; Headspace liquid micro-extraction, LC-GC Europe 2004; 17: 573-579.
15. Pfizer centre source, Triamcinalone, Pfizer.inc 2004.
16. Ahuja S., Residual solvents: Handbook of modern pharmaceutical analysis, Marcel Dekker publications, 2003. pp. 86-87.
17. Ahuja S., Gas chromatography: Handbook of modern pharmaceutical analysis, Marcel Dekker publications, 2003, pp.375-377.
18. Madichie C., Camarasu C.; Recent progress in the determination of volatile impurities in pharmaceuticals, Trends in analytical chemistry 2006; 25: 768-777.